Status:
TERMINATED
Use of Long-acting Bupivacaine In Lower Extremity Amputation
Lead Sponsor:
Loma Linda University
Conditions:
Amputation
Anesthesia, Local
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this investigator-initiated study is to assess the use of liposomal bupivacaine in major extremity amputation and its effects on post-operative opioid narcotic use, length of stay, and ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Patients who underwent unilateral or bilateral lower extremity major amputation, either primary or revision: partial foot, ankle disarticulation, transtibial, knee disarticulation, transfemoral \[1 year retrospective analysis\]
- Patients who meet clinical indication for unilateral or bilateral lower extremity major amputation, either primary or revision: partial foot, ankle disarticulation, transtibial, knee disarticulation, transfemoral
Exclusion
- Minor amputations
- Liver dysfunction (impaired metabolism of Amides)
- Concomitant psychiatric or chronic pain disorders
- Pregnancy
- Amide anesthetic allergy
- Presence of perioperative sepsis or acute organ dysfunction
- Need for ICU admission at any point
- Polytrauma
- Quadriplegic/Paraplegic/Insensate
Key Trial Info
Start Date :
April 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT04360421
Start Date
April 21 2020
End Date
August 1 2023
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center
Loma Linda, California, United States, 92354